Arasay, Nelia M.
HRN: 25-78-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/30/2024
MUPIROCIN 2%, 15G (TUBE)
08/30/2024
09/06/2024
TOPICAL
Apply Liberally On Affected Area
BID
Post OP Wound Prophylaxis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes